Status:
COMPLETED
Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
This non-interventional study is to analyse the therapeutic effectiveness in patients with severe COPD following a generally accepted 12-week treatment period with Symbicort Turbuhaler, which could an...
Eligibility Criteria
Inclusion
- non pregnant female
- COPD with persistent symptoms in spite of regular bronchodilator therapy
- Naive or fixed combination treated patients including patients already on Symbicort Turbuhaler
Exclusion
- Hypersensitivity to budesonide, formoterol or inhaled lactose
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
743 Patients enrolled
Trial Details
Trial ID
NCT00837629
Start Date
February 1 2007
End Date
September 1 2007
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.